← Back to catalogue

Hemosil Rivaroxaban Controls

FDA UDI

Class II (US FDA UDI)

by Instrumentation Laboratory Company

Identity

Trade Name
HEMOSIL RIVAROXABAN CONTROLS FDA UDI
Generic Name
Coagulation factor Xa inhibitor IVD, control FDA UDI
Device Name
1. Rivaroxaban Low Control (Cat. No. 0020015510): 5 x 1mL vials 2. Rivaroxaban High Control (Cat. No. 0020015520): 5 x 1mL vials FDA UDI
Model / Reference
0020015500 FDA UDI
Description
1. Rivaroxaban Low Control (Cat. No. 0020015510): 5 x 1mL vials 2. Rivaroxaban High Control (Cat. No. 0020015520): 5 x 1mL vials FDA UDI

Identifiers

Catalog Number
00020015500 FDA UDI
Primary DI / UDI-DI
08430793242998 FDA UDI
FDA Product Code
GGN FDA UDI
GMDN Term
Coagulation factor Xa inhibitor IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.5425 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Coagulation factor Xa inhibitor IVD, control

Hemosil Rivaroxaban Controls by Instrumentation Laboratory Company — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Coagulation factor Xa inhibitor IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI d791a557-6eed-4470-81b0-b99e823c75de 36 fields · synced Jun 8, 2026